Timothy M. Kuzel

Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma

Debra Breneman, Madeleine Duvic, Timothy M. Kuzel et al. · Archives of Dermatology · 2002 · 210 citations

Medicine, Oncology, Pharmacology +15

Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.

Timothy M. Kuzel, Henry H. Roenigk, Emma Samuelson et al. · Journal of Clinical Oncology · 1995 · 186 citations

Medicine, Dermatology, Pharmacotherapy +14

Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides

Mansoor N. Saleh, CF LeMaistre, Timothy M. Kuzel et al. · Journal of the American Academy of Dermatology · 1998 · 137 citations

Life Sciences, Immunology, Oncology +10

Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center

Christiane Querfeld, Neha Mehta, Steven T. Rosen et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 102 citations

Medicine, Immunology, Oncology +17

Interferon Alfa-2a Combined With Phototherapy in the Treatment of Cutaneous T-Cell Lymphoma

Timothy M. Kuzel, Kathy Gilyon, Elizabeth A. Springer et al. · JNCI Journal of the National Cancer Institute · 1990 · 96 citations

Medicine, Oncology, Pharmacotherapy +15